SUSAN BLANEY to Enzyme-Linked Immunosorbent Assay
This is a "connection" page, showing publications SUSAN BLANEY has written about Enzyme-Linked Immunosorbent Assay.
Connection Strength
0.077
-
A phase 1 study of the proteasome inhibitor bortezomib in pediatric patients with refractory leukemia: a Children's Oncology Group study. Clin Cancer Res. 2007 Mar 01; 13(5):1516-22.
Score: 0.058
-
Proteomic profiling of cerebrospinal fluid identifies prostaglandin D2 synthase as a putative biomarker for pediatric medulloblastoma: A pediatric brain tumor consortium study. Proteomics. 2011 Mar; 11(5):935-43.
Score: 0.019